Alex Teulé
6PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca
|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo
|Aug 08, 2024
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso
|May 23, 2023
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin.J Capdevila, J Hernando, A Teule
|Jul 02, 2021
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. <i>Cancers</i> 2020, <i>12</i>, 3419.Nuria Dueñas, Matilde Navarro, Àlex Teulé
Pageof 1
Frequent Collaborators
3 joint publications
Jaume Capdevila
3 joint publications
Rocio Garcia-Carbonero
2 joint publications
Alejandro Garcia-Alvarez
2 joint publications
Guillermo Crespo
2 joint publications
Ana Custodio
2 joint publications
Teresa Alonso-Gordoa
2 joint publications
Marta Benavent Viñuales
2 joint publications
Carlos Lopez
2 joint publications
Paula Jimenez-Fonseca
2 joint publications
Jorge Hernando